The IPO Buzz: Neumora Therapeutics Prices IPO in Range, RayzeBio Prices Upsized IPO at $18 – High End
A vanilla ice cream cone or a hot fudge sundae with the works: Two biotech IPOs took different approaches to pricing their deals on Thursday night (Sept. 14, 2023). Neumora Therapeutics (NMRA) priced its IPO in sync with the terms in its prospectus – 14.7 million shares at $17.00, the mid-point of its $16.00-to-$18.00 price […]
September 15, 2023 Read More